2026年9月25日 1:43 ET 发布 · 更新于 2 个月前 · 2 个来源
Novo Signs Delivery Deal With Nanexa Worth Up to $1.3 Billion
bloomberg
·
原始报道
Novo Nordisk A/S signed a deal worth as much as €1.165 billion ($1.3 billion) with Sweden’s Nanexa AB for rights to its drug delivery technology for obesity and diabetes treatments.
原文